MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ: MIRA · IEX Real-Time Price · USD
0.680
-0.031 (-4.34%)
At close: May 16, 2024, 3:59 PM
0.698
+0.018 (2.71%)
After-hours: May 16, 2024, 7:09 PM EDT
MIRA Pharmaceuticals Employees
MIRA Pharmaceuticals had 3 employees on March 28, 2024. The number of employees decreased by 3 or -50.00% since the number was reported on July 21, 2023.
Employees
3
Change
-3
Growth
-50.00%
Revenue / Employee
n/a
Profits / Employee
-$4,119,691
Market Cap
10.08M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 28, 2024 | 3 | -3 | -50.00% |
| Jul 21, 2023 | 6 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
MIRA News
- 6 weeks ago - Mira Pharmaceuticals Announces Encouraging Preclinical Results Advancing Ketamir-2 Towards Potential Year-End IND Submission - PRNewsWire
- 2 months ago - MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former Head of Pharmacology at Synthelabo, as Chief Scientific Advisor - PRNewsWire
- 3 months ago - MIRA Pharmaceuticals Provides Corporate Update - PRNewsWire
- 5 months ago - MIRA Pharmaceuticals Releases Breakthrough Data from Artificial Intelligence Simulations - PRNewsWire
- 6 months ago - MIRA Pharmaceuticals Announces Ketamir-2's Oral Bioavailability Predicted to be 80% - PRNewsWire
- 6 months ago - MIRA Pharmaceuticals To Host Shareholder Update Call on Tuesday, December 5, 2023 at 11:30 a.m. Eastern Time - PRNewsWire
- 6 months ago - MIRA Pharmaceuticals Announces Paradigm-Shift in Cognitive Enhancement with MIRA1a - PRNewsWire
- 6 months ago - MIRA Pharmaceuticals Announces Exclusive Licensing Agreement for Oral Ketamine Analog, Ketamir-2 - PRNewsWire